Diagnosis: Erythropoietic protoporphyria
A 7-year-old boy presents with severe burning pain and edema following sun exposure, lasting for several hours. Examination reveals erythematous, edematous areas on sun-exposed skin. The child has a history of similar episodes, raising suspicion for an underlying metabolic disorder associated with photosensitivity.
A 7-year-old male presents with a 2-year history of severe burning pain and edema following sun exposure. The episodes typically begin within minutes of sunlight exposure and can last several hours, causing significant discomfort. On examination, erythematous and edematous plaques are noted on the face and dorsum of the hands.Age: 7 yearsSex: MaleDuration of symptoms: 2 yearsKey complaint: Burning pain and edema after sun exposureExam findings: Erythematous and edematous plaques on sun-exposed areas
The patient first noticed symptoms at age 5, with episodes triggered by direct sunlight. There is no significant family history of similar symptoms, although the patient's mother reports occasional skin sensitivity. The child has not received any prior treatments for these episodes, and there are no significant past medical or social histories noted. Sun exposure is a consistent trigger, and the patient enjoys outdoor activities.Onset: Symptoms began at age 5Triggers: Direct sunlight exposurePrior treatments: NoneFamily history: No known history of photosensitivity disordersSocial history: Active outdoor lifestyle
Acute / First-Line ManagementCool compresses to affected areas for symptomatic relief.Analgesics such as ibuprofen (10 mg/kg/dose every 6-8 hours as needed) for pain management.Topical corticosteroids (e.g., hydrocortisone 1% cream) may be applied to reduce inflammation.Workup and Diagnostic ConfirmationPlasma and urine porphyrin levels to assess for abnormalities.Genetic testing for mutations in the FECH gene to confirm diagnosis.Skin biopsy may be considered to evaluate for histological changes associated with porphyria.Long-Term ManagementSun protection with broad-spectrum sunscreen (SPF 50 or higher) and protective clothing.Consideration of beta-carotene supplementation (15-30 mg daily) as a preventive measure against photosensitivity.Regular follow-up with a dermatologist for monitoring and management of symptoms.
Porphyria cutanea tarda: Typically presents with blistering and photosensitivity, but more commonly affects adults and is associated with liver disease.Solar urticaria: Characterized by whealing and pruritus upon sun exposure, often within minutes, resolving within hours.Polymorphous light eruption: A common photodermatosis presenting with erythematous papules and plaques after sun exposure, typically affecting women in early spring.Atopic dermatitis: Can be exacerbated by sun exposure but usually presents with chronic eczematous lesions and a history of atopy.Contact dermatitis: May present with localized erythema and edema, but would typically have an identifiable contact allergen.Systemic lupus erythematosus: Photosensitivity can occur, but systemic signs and symptoms would be present, and the lesions often have a different morphology.Chronic actinic dermatitis: Characterized by eczematous lesions primarily in sun-exposed areas, often in older patients with a history of atopic dermatitis.Acute sunburn: Presents with erythema and pain but typically lacks the severe burning pain and edema seen in this case.
High-Yield PearlsPhotosensitivity: Erythropoietic protoporphyria (EPP) is characterized by acute photosensitivity and pain, often misdiagnosed as sunburn.Genetics: EPP is caused by mutations in the FECH gene leading to decreased protoporphyrin IX metabolism.Diagnosis: Confirmatory tests include porphyrin levels and genetic testing; high levels of protoporphyrin in erythrocytes are indicative.Management: Sun protection is critical; patients should use high-SPF sunscreen and protective clothing.Long-term care: Regular dermatology follow-up is essential to manage symptoms and prevent complications.Recognizing the signs of erythropoietic protoporphyria early can prevent significant morbidity associated with this rare disorder.
Tags: EPP, porphyria